Survival Analysis of Patients With Stage I Non–Small-Cell Lung Cancer Using Clinical and DNA Repair Pathway Expression Variables
Madhusmita Behera(National Institutes of Health), Suresh S. Ramalingam(Emory University), Gabriel Sica(Emory University), William Mayfield(WellStar Health System), Fadlo R. Khuri(American University of Beirut Medical Center), Robert W. Fu(Emory University), Róbert Hermann(Rutgers, The State University of New Jersey), Ha Tran(Emory University), John Heine, Erin Fowler(Moffitt Cancer Center), Anthony A. Gal(Emory University), Taofeek K. Owonikoko(UPMC Hillman Cancer Center)
Cited by 4
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k